Active Biotech AB (ACTI) — Tangible Net Worth Ratio
Active Biotech AB (ACTI) has a Tangible Net Worth Ratio of 95.6% as of September 2025. This metric is calculated by deducting intangible assets (Skr200.00K) from net assets (Skr4.50 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Active Biotech AB shareholders equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Active Biotech AB Tangible Net Worth Ratio (2000–2024)
This chart shows how Active Biotech AB's Tangible Net Worth Ratio has changed across 25 annual periods from 2000 to 2024. As of September 2025, the ratio stands at 95.6%, reflecting net assets of Skr4.50 Million with intangible assets of Skr200.00K SEK. Also explore ACTI net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Active Biotech AB (2000–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Active Biotech AB from 2000 to 2024, covering 25 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see ACTI company net worth.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 99.2% | Skr32.07 Million | Skr245.00K | Skr43.20 Million | ▲ +0.0 pp |
| 2023 | 99.2% | Skr30.67 Million | Skr245.00K | Skr44.05 Million | ▼ -0.1 pp |
| 2022 | 99.3% | Skr34.51 Million | Skr245.00K | Skr51.01 Million | ▼ -0.7 pp |
| 2021 | 100.0% | Skr46.67 Million | Skr0.00 | Skr56.80 Million | ▲ +0.0 pp |
| 2020 | 100.0% | Skr22.11 Million | Skr0.00 | Skr32.16 Million | ▲ +0.0 pp |
| 2019 | 100.0% | Skr53.78 Million | Skr0.00 | Skr66.95 Million | ▲ +0.0 pp |
| 2018 | 100.0% | Skr87.92 Million | Skr0.00 | Skr302.43 Million | ▲ +0.0 pp |
| 2017 | 100.0% | Skr77.68 Million | Skr0.00 | Skr303.81 Million | ▲ +0.0 pp |
| 2016 | 100.0% | Skr182.56 Million | Skr0.00 | Skr412.88 Million | ▲ +0.0 pp |
| 2015 | 100.0% | Skr180.60 Million | Skr0.00 | Skr449.44 Million | ▲ +0.0 pp |
| 2014 | 100.0% | Skr405.31 Million | Skr0.00 | Skr722.52 Million | ▲ +0.0 pp |
| 2013 | 100.0% | Skr405.41 Million | Skr0.00 | Skr767.81 Million | ▲ +0.0 pp |
| 2012 | 100.0% | Skr339.92 Million | Skr0.00 | Skr696.74 Million | ▲ +0.0 pp |
| 2011 | 100.0% | Skr501.99 Million | Skr0.00 | Skr858.52 Million | ▲ +0.0 pp |
| 2010 | 100.0% | Skr181.76 Million | Skr0.00 | Skr503.10 Million | ▲ +0.0 pp |
| 2009 | 100.0% | Skr188.64 Million | Skr0.00 | Skr498.50 Million | ▲ +0.0 pp |
| 2008 | 100.0% | Skr163.61 Million | Skr0.00 | Skr472.95 Million | ▲ +0.0 pp |
| 2007 | 100.0% | Skr189.57 Million | Skr0.00 | Skr489.54 Million | ▲ +0.0 pp |
| 2006 | 100.0% | Skr60.36 Million | Skr0.00 | Skr462.40 Million | ▲ +0.0 pp |
| 2005 | 100.0% | Skr176.81 Million | Skr0.00 | Skr567.86 Million | ▲ +0.0 pp |
| 2004 | 100.0% | Skr162.30 Million | Skr0.00 | Skr312.89 Million | ▲ +0.0 pp |
| 2003 | 100.0% | Skr289.58 Million | Skr0.00 | Skr345.40 Million | ▲ +0.0 pp |
| 2002 | 100.0% | Skr380.27 Million | Skr0.00 | Skr467.50 Million | ▲ +0.0 pp |
| 2001 | 100.0% | Skr678.78 Million | Skr0.00 | Skr747.74 Million | ▲ +7.3 pp |
| 2000 | 92.7% | Skr646.03 Million | Skr47.14 Million | Skr868.95 Million | — |